These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 39028949)

  • 1. Exploring the Darobactin Class of Antibiotics: A Comprehensive Review from Discovery to Recent Advancements.
    Dutta A; Sharma P; Dass D; Yarlagadda V
    ACS Infect Dis; 2024 Aug; 10(8):2584-2599. PubMed ID: 39028949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutasynthetic Production and Antimicrobial Characterization of Darobactin Analogs.
    Böhringer N; Green R; Liu Y; Mettal U; Marner M; Modaresi SM; Jakob RP; Wuisan ZG; Maier T; Iinishi A; Hiller S; Lewis K; Schäberle TF
    Microbiol Spectr; 2021 Dec; 9(3):e0153521. PubMed ID: 34937193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome- and metabolome-guided discovery of marine BamA inhibitors revealed a dedicated darobactin halogenase.
    Böhringer N; Kramer JC; de la Mora E; Padva L; Wuisan ZG; Liu Y; Kurz M; Marner M; Nguyen H; Amara P; Yokoyama K; Nicolet Y; Mettal U; Schäberle TF
    Cell Chem Biol; 2023 Aug; 30(8):943-952.e7. PubMed ID: 37451267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Darobactin Substrate Engineering and Computation Show Radical Stability Governs Ether versus C-C Bond Formation.
    Woodard AM; Peccati F; Navo CD; Jiménez-Osés G; Mitchell DA
    J Am Chem Soc; 2024 May; 146(20):14328-14340. PubMed ID: 38728535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new antibiotic selectively kills Gram-negative pathogens.
    Imai Y; Meyer KJ; Iinishi A; Favre-Godal Q; Green R; Manuse S; Caboni M; Mori M; Niles S; Ghiglieri M; Honrao C; Ma X; Guo JJ; Makriyannis A; Linares-Otoya L; Böhringer N; Wuisan ZG; Kaur H; Wu R; Mateus A; Typas A; Savitski MM; Espinoza JL; O'Rourke A; Nelson KE; Hiller S; Noinaj N; Schäberle TF; D'Onofrio A; Lewis K
    Nature; 2019 Dec; 576(7787):459-464. PubMed ID: 31747680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved broad-spectrum antibiotics against Gram-negative pathogens
    Groß S; Panter F; Pogorevc D; Seyfert CE; Deckarm S; Bader CD; Herrmann J; Müller R
    Chem Sci; 2021 Sep; 12(35):11882-11893. PubMed ID: 34659729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radical SAM-dependent ether crosslink in daropeptide biosynthesis.
    Guo S; Wang S; Ma S; Deng Z; Ding W; Zhang Q
    Nat Commun; 2022 Apr; 13(1):2361. PubMed ID: 35487921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Darobactins Exhibiting Superior Antibiotic Activity by Cryo-EM Structure Guided Biosynthetic Engineering.
    Seyfert CE; Porten C; Yuan B; Deckarm S; Panter F; Bader CD; Coetzee J; Deschner F; Tehrani KHME; Higgins PG; Seifert H; Marlovits TC; Herrmann J; Müller R
    Angew Chem Int Ed Engl; 2023 Jan; 62(2):e202214094. PubMed ID: 36308277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzylic Radical Stabilization Permits Ether Formation During Darobactin Biosynthesis.
    Woodard AM; Peccati F; Navo CD; Jiménez-Osés G; Mitchell DA
    bioRxiv; 2023 Nov; ():. PubMed ID: 38076856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of heterologous Darobactin A expression and identification of the minimal biosynthetic gene cluster.
    Wuisan ZG; Kresna IDM; Böhringer N; Lewis K; Schäberle TF
    Metab Eng; 2021 Jul; 66():123-136. PubMed ID: 33872780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational identification of a systemic antibiotic for gram-negative bacteria.
    Miller RD; Iinishi A; Modaresi SM; Yoo BK; Curtis TD; Lariviere PJ; Liang L; Son S; Nicolau S; Bargabos R; Morrissette M; Gates MF; Pitt N; Jakob RP; Rath P; Maier T; Malyutin AG; Kaiser JT; Niles S; Karavas B; Ghiglieri M; Bowman SEJ; Rees DC; Hiller S; Lewis K
    Nat Microbiol; 2022 Oct; 7(10):1661-1672. PubMed ID: 36163500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Silent Operon of Photorhabdus luminescens Encodes a Prodrug Mimic of GTP.
    Shahsavari N; Wang B; Imai Y; Mori M; Son S; Liang L; Böhringer N; Manuse S; Gates MF; Morrissette M; Corsetti R; Espinoza JL; Dupont CL; Laub MT; Lewis K
    mBio; 2022 Jun; 13(3):e0070022. PubMed ID: 35575547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a Radical SAM Oxygenase for the Ether Crosslinking in Darobactin Biosynthesis.
    Nguyen H; Made Kresna ID; Böhringer N; Ruel J; Mora E; Kramer JC; Lewis K; Nicolet Y; Schäberle TF; Yokoyama K
    J Am Chem Soc; 2022 Oct; 144(41):18876-18886. PubMed ID: 36194754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial Activity of Ceftazidime-Avibactam, Ceftolozane-Tazobactam, Cefiderocol, and Novel Darobactin Analogs against Multidrug-Resistant Pseudomonas aeruginosa Isolates from Pediatric and Adolescent Cystic Fibrosis Patients.
    Marner M; Kolberg L; Horst J; Böhringer N; Hübner J; Kresna IDM; Liu Y; Mettal U; Wang L; Meyer-Bühn M; Mihajlovic S; Kappler M; Schäberle TF; von Both U
    Microbiol Spectr; 2023 Feb; 11(1):e0443722. PubMed ID: 36692293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mimicry of a Non-ribosomally Produced Antimicrobial, Brevicidine, by Ribosomal Synthesis and Post-translational Modification.
    Zhao X; Li Z; Kuipers OP
    Cell Chem Biol; 2020 Oct; 27(10):1262-1271.e4. PubMed ID: 32707039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Genetically Engineered Derivatives of Antibacterial Darobactins Underpin Their Potential for Antibiotic Development.
    Seyfert CE; Müller AV; Walsh DJ; Birkelbach J; Kany AM; Porten C; Yuan B; Krug D; Herrmann J; Marlovits TC; Hirsch AKH; Müller R
    J Med Chem; 2023 Dec; 66(23):16330-16341. PubMed ID: 38093695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antibiotic darobactin mimics a β-strand to inhibit outer membrane insertase.
    Kaur H; Jakob RP; Marzinek JK; Green R; Imai Y; Bolla JR; Agustoni E; Robinson CV; Bond PJ; Lewis K; Maier T; Hiller S
    Nature; 2021 May; 593(7857):125-129. PubMed ID: 33854236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rule-based omics mining reveals antimicrobial macrocyclic peptides against drug-resistant clinical isolates.
    Cheng Z; He BB; Lei K; Gao Y; Shi Y; Zhong Z; Liu H; Liu R; Zhang H; Wu S; Zhang W; Tang X; Li YX
    Nat Commun; 2024 Jun; 15(1):4901. PubMed ID: 38851779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chimeric peptidomimetic antibiotics against Gram-negative bacteria.
    Luther A; Urfer M; Zahn M; Müller M; Wang SY; Mondal M; Vitale A; Hartmann JB; Sharpe T; Monte FL; Kocherla H; Cline E; Pessi G; Rath P; Modaresi SM; Chiquet P; Stiegeler S; Verbree C; Remus T; Schmitt M; Kolopp C; Westwood MA; Desjonquères N; Brabet E; Hell S; LePoupon K; Vermeulen A; Jaisson R; Rithié V; Upert G; Lederer A; Zbinden P; Wach A; Moehle K; Zerbe K; Locher HH; Bernardini F; Dale GE; Eberl L; Wollscheid B; Hiller S; Robinson JA; Obrecht D
    Nature; 2019 Dec; 576(7787):452-458. PubMed ID: 31645764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small Molecule Antibiotics Inhibit Distinct Stages of Bacterial Outer Membrane Protein Assembly.
    Peterson JH; Doyle MT; Bernstein HD
    mBio; 2022 Oct; 13(5):e0228622. PubMed ID: 36165532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.